A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics
Clinical trial NCT04603989 · COMPLETED
Trial details
- NCT number
- NCT04603989
- Sponsor
- Guangzhou Henovcom Bioscience Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2020-11-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.